Initially identified in 2011 as the major susceptibility gene for Moyamoya disease (MMD), a rare cerebrovascular disorder characterized by progressive stenosis of intracranial arteries, RNF213 has since been implicated in various subtypes of ischemic stroke [5,6]. The gene discussed is RNF213; the disease is multiminicore myopathy.